The presence of this antibody impairs the function of granulocyte-macrophage colony-stimulating factor, resulting in increased number of alveolar lipoproteins that eventually lead to pulmonary alveolar proteinosis. The gene discussed is CSF2; the disease is pulmonary alveolar proteinosis.